Could late measurement of serum creatinine be missed for patients without early increase in serum creatinine following coronary angiography?

Abstract Most patients are discharged early (within 24 hours) after coronary angiography (CAG) and may miss identification the late (24–48 hours) increase in serum creatinine (SCr), whose characteristics and prognosis have been less intensively investigated. We prospectively recruited 3065 consecutive patients with SCr measurement, including only1344 patients with twice SCr measurement (both early and late). The late contrast-induced acute kidney injury (CI-AKI) was defined as significantly increase in SCr (≥0.3 mg/dL or ≥50%) not in early phase, but only in late phase after the procedure, and the early CI-AKI experienced a significantly increase in early phase. Overall, CI-AKI developed in 134 patients (10%), and the incidence of late and early CI-AKI were 3.6% and 6.4%, respectively. There were no difference in age, renal, and heart function, contrast volume among patients with late and early CI-AKI. With mean follow-up period of 2.45 years, long-term mortality (3 years, 29.7% and 35.6%, respectively, P = .553) was similar for patients with late and early CI-AKI. Cox analysis showed that both late (adjusted HR 2.05; 95% CI, 1.02–4.15) and early (adjusted HR 2.68; 95% CI, 1.57–4.59) CI-AKI was significantly associated with long-term mortality (all P < .001). Only late increase in SCr, as late CI-AKI, accounted for about one-third of CI-AKI incidence and has similar good predictive value for long-term mortality with that of an early increase, early CI-AKI, among patients with SCr measured twice, supporting the importance of late repeating SCr measurement after CAG, even without an early significant increase in SCr.

[1]  F. Lombardi,et al.  A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2016, International journal of cardiology.

[2]  Ping-yan Chen,et al.  Safe Limits of Contrast Vary With Hydration Volume for Prevention of Contrast-Induced Nephropathy After Coronary Angiography Among Patients With a Relatively Low Risk of Contrast-Induced Nephropathy , 2015, Circulation. Cardiovascular interventions.

[3]  A. Durante,et al.  Contrast-Induced Nephropathy in Percutaneous Coronary Interventions: Pathogenesis, Risk Factors, Outcome, Prevention and Treatment , 2014, Cardiology.

[4]  G. Stone,et al.  B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction: A Substudy from the HORIZONS-AMI Trial , 2012, Circulation. Cardiovascular interventions.

[5]  G. Gambaro,et al.  Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. , 2012, Clinical chemistry.

[6]  P. Aspelin,et al.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines , 2011, European Radiology.

[7]  Hani Jneid,et al.  2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in , 2011, Journal of the American College of Cardiology.

[8]  A. Colombo,et al.  Impact of contrast-induced acute kidney injury definition on clinical outcomes. , 2011, American heart journal.

[9]  Richard Solomon,et al.  Contrast-induced acute kidney injury. , 2010, Circulation.

[10]  G. Gambaro,et al.  Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. , 2010, The American journal of medicine.

[11]  Liu Xun,et al.  Assessing glomerular filtration rate (GFR) in elderly Chinese patients with chronic kidney disease (CKD): a comparison of various predictive equations. , 2010, Archives of gerontology and geriatrics.

[12]  A. Colombo,et al.  Cystatin C and Contrast-Induced Acute Kidney Injury , 2010, Circulation.

[13]  W. Laskey,et al.  Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. , 2007, Journal of the American College of Cardiology.

[14]  P. Aspelin,et al.  Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach , 2006, Circulation.

[15]  R. Mehran,et al.  Contrast-induced nephropathy: definition, epidemiology, and patients at risk. , 2006, Kidney international. Supplement.

[16]  B. Barrett,et al.  Follow-up of patients with contrast-induced nephropathy. , 2006, Kidney international. Supplement.

[17]  G. Deray,et al.  How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. , 2006, Kidney international. Supplement.

[18]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[19]  William W O'Neill,et al.  Determinants of serum creatinine trajectory in acute contrast nephropathy. , 2002, Journal of interventional cardiology.

[20]  T. Arakawa,et al.  Admission hyperglycemia is an independent predictor of acute kidney injury in patients with acute myocardial infarction. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[21]  M. Bissell Comparison of Serum Creatinine and Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy after Coronary Angiography and Interventions , 2013 .

[22]  Jiyan Chen,et al.  Contrast medium volume to creatinine clearance ratio: A predictor of contrast‐induced nephropathy in the first 72 hours following percutaneous coronary intervention , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.